<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Biomarkers":3,
"Bladder cancer":3,
"Estrogen metabolites":1,
"Infertility":1,
"Schistosoma haematobium":1,
"Breast":1,
"elastography":2,
"fat-to-lesion speed ratio":1,
"gland-to-lesion speed ratio":1,
"shear wave speed imaging":1,
"ultrasound":8,
"breast cancer":10,
"disease-free survival":1,
"human epidermal growth factor receptor-2":1,
"overall survival":2,
"prognosis":6,
"sentinel lymph node metastasis":1,
"Atypia of undetermined significance":1,
"Bethesda system of reporting thyroid cytology":1,
"follicular lesion of undetermined significance":1,
"malignancy rate":1,
"Shenzhen":1,
"cancer registry":1,
"epidemiology":2,
"incidence":2,
"malignancy":2,
"cancer":9,
"cervical carcinoma":1,
"mast cell":1,
"melanoma":1,
"systemic mast cell activation disease":1,
"systemic mast cell activation syndrome":1,
"systemic mastocytosis":1,
"Ki-67":1,
"atypical carcinoid":1,
"carcinoid":1,
"neuroendocrine neoplasm":1,
"orthopedia homeobox protein (OTP)":1,
"thyroid transcription factor 1 (TTF-1)":1,
"favorable outcome":1,
"meta-analysis":3,
"solid tumor":1,
"tumor-infiltrating CD57+ lymphocytes":1,
"Adenocarcinoma":1,
"Glioma":2,
"Nasopharyngeal carcinoma":1,
"Papillary carcinoma":4,
"Radiotherapy":3,
"Nasopharynx":1,
"Papillary adenocarcinoma":1,
"TTF-1":1,
"Thyroid-like low-grade nasopharyngeal papillary carcinoma":1,
"cachexia":1,
"exosomes":1,
"tumour progression":1,
"Central airway obstruction":1,
"Oxygen reserve index (ORi)":1,
"Pulse oximetry":1,
"Rigid bronchoscopy":1,
"Tracheal stent":1,
"Thyroid":15,
"extraocular muscle":1,
"orbitopathy":1,
"paraneoplastic syndrome":2,
"HbA1c":1,
"irAE":1,
"lung cancer":1,
"nivolumab":1,
"type 1 diabetes mellitus":1,
"Coffee":1,
"Cohort":3,
"EPIC":1,
"Intake":1,
"Tea":1,
"Thyroid cancer":33,
"laser":1,
"nodule":1,
"radioactive treatment":1,
"surgery":2,
"thermal ablation":2,
"toxic adenoma":1,
"Anaplastic carcinoma":1,
"ETV6 gene rearrangement":1,
"Mammary analogue secretory carcinoma":1,
"Lymph nodes":2,
"Metastases":1,
"Ultrasound examination":1,
"Anaplastic thyroid cancer":3,
"Inhibitors":1,
"Mutations":1,
"Signaling":1,
"Therapeutics":2,
"Tumor":4,
"Breast neoplasms":4,
"Drug therapy":1,
"Pregnancy":1,
"Medullary thyroid carcinoma":4,
"multiple endocrine neoplasia type 2B":1,
"submucosal neuroma":1,
"Adamantinoma-like Ewing sarcoma":1,
"Ewing sarcoma":1,
"Molecular diagnostics":1,
"Sarcoma":1,
"Follow-up studies":1,
"Immunohistochemistry":3,
"Neoplasms, vascular tissue":1,
"STAT6":1,
"Solitary fibrous tumors":1,
"Thyroid gland":8,
"RET mutation":1,
"cabozantinib":2,
"spontaneous regression":1,
"tyrosine kinase inhibitors":1,
"vandetanib":3,
"BRAF":5,
"ETV6/NTRK3":1,
"Papillary thyroid carcinoma":26,
"RAS":3,
"RET/PTC":1,
"TERT":1,
"Tracheal resection":1,
"Tracheoplasty":1,
"Cancer risks":1,
"Deglutition disorders":1,
"Fluoroscopy":1,
"Radiation exposure":1,
"ZEB1":1,
"Zinc finger E-box-binding homeobox 1":1,
"miR-429":1,
"Papillary thyroid cancer":13,
"aerodigestive tract invasion":1,
"aggressive thyroid cancer":1,
"tracheoesophageal groove":1,
"Euthyroid":1,
"thyroid function":1,
"breast carcinoma":1,
"carcinome mammaire":1,
"invasion":4,
"migration":4,
"otoraplin":1,
"otorapline":1,
"proliferation":4,
"prolifération":1,
"Hypoparathyroidism":2,
"Recurrent nerve injury":1,
"Reoperative thyroid surgery":1,
"Total thyroidectomy":2,
"Color Doppler ultrasound":1,
"FNA":3,
"Malignant thyroid nodule":1,
"Thyroid nodule":10,
"Papillary cancer":1,
"Thyroidectomy":7,
"Thyroiditis":1,
"Cytokeratin 19":1,
"biomarker":4,
"disseminated tumor cells":1,
"neoplasm diagnosis":1,
"neoplasm prognosis":1,
"EMT":2,
"UCA1":1,
"miR-15a":1,
"Integrated bioinformatics analysis":1,
"MMP13":1,
"MMP3":1,
"Adverse effects":2,
"Antilles":1,
"Chlordecone":1,
"Chlordécone":1,
"Effets indésirables":1,
"Neurodevelopmental disorders":1,
"Pesticides":1,
"Prostatic neoplasms":1,
"Troubles du développement neurologique":1,
"Tumeurs de la prostate":1,
"West Indies":1,
"14-3-3ζ":1,
"nicotinamide phosphoribosyltransferase":1,
"pyruvate kinase M2":1,
"tamoxifen resistance":1,
"KRAS":1,
"Let-7g":1,
"TN":1,
"cell proliferation":1,
"rs712":1,
"BRAF V600E mutation":2,
"microarray analysis":1,
"papillary thyroid carcinomas":3,
"GEO":1,
"bioinformatics":1,
"differentially expressed genes":2,
"robust rank aggregation":1,
"Central hyperthyroidism":1,
"Free T3":1,
"Free T4":1,
"Resistance to thyroid hormones":1,
"Somatostatin analogs":1,
"TSH-oma":1,
"Thyrotropin":1,
"Thyrotropin-secreting pituitary adenoma":1,
"Transsphenoidal surgery":1,
"fine-needle aspiration":4,
"magnetic field":1,
"needle guidance":1,
"Hypothyroidism":2,
"Levothyroxine dose adjustment":1,
"Real life":1,
"TSH variability":1,
"Chinese":1,
"anaplastic thyroid carcinoma":7,
"poorly differentiated thyroid carcinoma":3,
"thyroid carcinoma":8,
"Phonatory function":1,
"Recurrent laryngeal nerve":1,
"Well-differentiated thyroid carcinoma":1,
"computer-aided diagnosis":1,
"childhood cancer survivor":1,
"second primary malignancy":1,
"survival":4,
"ceRNA network":1,
"lncRNA":1,
"nomogram":1,
"tumor recurrence":1,
"Fine needle aspiration":2,
"Quality of care":1,
"Thyroid ultrasound":1,
"Obesity":2,
"TSH":1,
"CpG signature":1,
"DNA methylation profiling":1,
"diagnosis":4,
"long non-coding RNA H19":2,
"molecular therapy":1,
"tumorigenesis":1,
"c-ret":1,
"carcinoma":5,
"epigenomics":1,
"genes":1,
"genetics":1,
"medullary":2,
"proto-oncogene proteins":1,
"thyroid neoplasms":4,
"Patient-doctor relationship":1,
"Preoperative":1,
"Qualitative":1,
"Reassurance":1,
"Anaplastic thyroid carcinoma (ATC)":1,
"Smad":1,
"epithelial-to-mesenchymal transition":1,
"transforming growth factor":1,
"Fine-needle aspiration (FNA)":1,
"Follow-up":1,
"Indeterminate nodules":2,
"MicroRNA-4500":1,
"Papillary thyroid cancer (PTC)":2,
"Plexin C1 (PLXNC1)":1,
"Sonography":1,
"TERT C228T mutation":1,
"clinic-pathological characteristics":1,
"pediatric papillary thyroid cancer":1,
"2-dimensional difference gel electrophoresis":1,
"Autoantibodies":1,
"Serological proteome analysis":1,
"Glial fibrillary acidic protein":1,
"antibody":1,
"astrocytopathy":1,
"central nervous system":1,
"Hub genes":1,
"Lymph node metastasis":5,
"Weighted gene co-expression network analysis":1,
"Acinar cell carcinoma":1,
"Differential diagnosis":2,
"Morphology":1,
"Pancreas":1,
"Thyroid-like":1,
"Adequacy":1,
"Nodal yield":1,
"De Quervain's":1,
"cytological features":1,
"subacute granulomatous thyroiditis":1,
"pediatric thyroid cancer":1,
"recurrence":3,
"Aggressiveness":1,
"Epithelial to mesenchymal transition":3,
"Metastasis":8,
"EZH2":1,
"H3K27me3":1,
"1H-NMR":1,
"FAAS":1,
"IR":1,
"MTT assay":1,
"Nickel":1,
"Schiff base":1,
"Bethesda thyroid cytopathology":1,
"cell block":1,
"Extrathyroidal extension":3,
"Hemithyroidectomy":2,
"Propensity score matching":1,
"ARMS-PCR":1,
"clinicopathological features":1,
"FVPTC":1,
"NIFTP":2,
"follicular variant of papillary carcinoma":1,
"noninvasive EFVPTC":1,
"differentiated thyroid carcinoma":4,
"high sensitive":1,
"prognostic biomarkers":2,
"thyroglobulin":2,
"Deiodinase":1,
"Glioblastoma":1,
"encapsulated variant":1,
"follicular":1,
"papillary":2,
"CT":1,
"machine learning":1,
"radiomics":1,
"thyroid nodules":3,
"HAM-1":1,
"In situ hybridization":1,
"Long non-coding RNA":1,
"PCA3":1,
"PCR array":1,
"RT-PCR":1,
"Heterogeneity":1,
"RNA-seq":1,
"anthropometric parameters":1,
"case-control study":1,
"differentiated thyroid cancer":4,
"Korea":1,
"lenvatinib":5,
"lesion-based evaluation":1,
"progressive disease":1,
"calcitonin":1,
"cyto-histological correlation":1,
"fine needle cytology":1,
"mutational analysis":1,
"thyroid cancer treatment":1,
"ultrasound features":1,
"Flow cytometry":1,
"Immunoglobulin heavy chain rearrangement":1,
"Karyotypic analysis":1,
"Mucosa-associated lymphoid tissue":1,
"Thyroid lymphoma":1,
"Cardiac myxoma":1,
"Carney complex":1,
"Pituitary apoplexy":1,
"Pituitary tumor":1,
"benign thyroid disorder":1,
"immune system":1,
"radioiodine therapy":1,
"Cell migration":1,
"E-cadherin":3,
"Epithelial-mesenchymal transition (EMT)":1,
"REGγ":1,
"Prognostic factors for survival":1,
"Staging systems":1,
"Cervical lymph node metastasis":1,
"Prognostic factors":1,
"RET proto-oncogene mutation":1,
"Surgical treatment":1,
"health insurance":1,
"healthcare disparities":1,
"microcarcinoma":1,
"overtreatment":1,
"cytology":3,
"fine-needle biopsy":1,
"Clinical knowledge":1,
"Convolutional neural networks":1,
"Ultrasound image":1,
"Glycolysis metabolism":1,
"Membrane penetration":1,
"Multivalent helical polypeptide":1,
"Photothermal therapy":1,
"Starvation therapy":1,
"siRNA delivery":1,
"Chemoresistance":2,
"Colorectal cancer":1,
"DOT1L":1,
"H3K79me2":1,
"Stemness":2,
"miR-133b":1,
"AUS/FLUS":1,
"BRAF V600E":3,
"Thyroid fine needle aspiration":1,
"Epiduritis":1,
"Metastatic spreading":1,
"Spine metastases":1,
"Vertebrae":1,
"Thyroid surgery":3,
"Astraxanthin":1,
"HMG-CoAR":1,
"Keap1":1,
"NF-kB":1,
"Nrf-2":1,
"antioxidant":1,
"metabolizing enzymes":1,
"solid lipid nanoparticles":1,
"PSMB8":1,
"miR-451a":1,
"miRNAs":1,
"cell division":1,
"geriatric oncology":1,
"oncogenesis":1,
"transcriptome":1,
"Apoptosis":2,
"Autophagy":1,
"BCPAP cells":1,
"BRAF kinase":1,
"Iodine":2,
"GAP43":1,
"oncogene":1,
"imaging":1,
"optical coherence tomography":1,
"parathyroid":2,
"tissue biopsy":1,
"hypopharyngeal cancer":1,
"miRNA":1,
"score":1,
"signature":1,
"endocrine":1,
"surveillance":1,
"Molecular markers":1,
"Sistrunk’s procedure":1,
"Thyroglossal cyst carcinoma":1,
"circulating tumor cells (CTCs)":1,
"Surgicel":1,
"foreign-body reaction":1,
"oxidized cellulose":1,
"pseudotumor":1,
"Hedgehog pathway":1,
"LncRNA LINC01510":1,
"SHH":1,
"miR-335":1,
"radioiodine-refractory differentiated thyroid carcinoma":1,
"salvage treatment":1,
"sorafenib":4,
"oral contraceptive use":1,
"reproductive factors":1,
"Monte Carlo simulation":1,
"carbon-ion radiotherapy":1,
"out-of-field dose":1,
"pediatric cancer":2,
"Core needle biopsy":1,
"Encapsulated follicular variant of papillary thyroid carcinoma":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"Risk of malignancy":1,
"CDK12":1,
"Ser2 phosphorylation of pol II CTD":1,
"Super enhancer":1,
"THZ531":1,
"BRAF protein, human":1,
"Head and neck neoplasms":1,
"Mutation":1,
"Protein-tyrosine kinase":1,
"RET":4,
"Dedifferentiated thyroid cancer":1,
"IL-6/STAT3 signaling pathway":1,
"nevirapine":1,
"Anaplastic thyroid cancer (ATC)":1,
"Anti-PD-1 antibody":1,
"Checkpoint inhibitor":1,
"Pembrolizumab":1,
"Kidney transplant recipients":1,
"Kidney transplantation":1,
"Pretransplant":1,
"Sanger sequencing":1,
"familial nonmedullary thyroid cancer":1,
"genetic mutation":1,
"targeted gene sequencing":1,
"whole-exome sequencing":1,
"Epithelial-mesenchymal transition":1,
"TRIP13":1,
"TTC5":1,
"Tumor metastasis":1,
"p53":1,
"Chemotherapy":2,
"Immunotherapy":1,
"Palliative surgery":1,
"Pulmonary adenocarcinoma":1,
"Rectal metastasis":1,
"growth activity":1,
"kinetic analysis":1,
"papillary microcarcinoma":1,
"lymphocyte":1,
"monocyte":1,
"neutrophil":1,
"platelet":1,
"ratio":1,
"thyrotoxicosis":1,
"Assessment":1,
"Cardiovascular risk":1,
"Risk factors":1,
"Secondary hypertension":1,
"Target organ damage":1,
"Intratumor heterogeneity":1,
"Lymph node":3,
"Mass spectrometry imaging":1,
"Proteomics":2,
"magnetic probe":1,
"sentinel lymph node biopsy":1,
"superparamagnetic iron oxide":1,
"AMPK":1,
"Cell":1,
"PKM2":2,
"β-catenin":2,
"double-blind":1,
"logistic regression model":1,
"metabolomics":1,
"False-negative diagnoses":1,
"False-positive diagnoses":1,
"Angioinvasion":1,
"Extranodal extension":1,
"Follicular thyroid carcinoma":3,
"TERT promoter":1,
"Variants":1,
"Cowden syndrome":1,
"Rare papillary thyroid carcinoma subtypes":1,
"TERT promoter mutation":1,
"Active surveillance":2,
"Dynamic risk stratification":1,
"Radioactive iodine":1,
"Treatment":1,
"Tyrosine kinase inhibitor":2,
"Aggressive":1,
"Medullary thyroid cancer":2,
"TOETVA":1,
"endoscopic thyroidectomy":2,
"transoral":1,
"Metastatic":1,
"Skin":1,
"Germ cell tumors":1,
"Malignant struma ovarii":1,
"Struma ovarii":2,
"Struma ovarii with malignant transformation":1,
"Esophageal squamous cell carcinoma":1,
"epithelial–mesenchymal transition":1,
"miR-25":1,
"echogenicity":1,
"nodular goiters":1,
"ultrasonic diagnosis":1,
"ultrasound gray scale ratio":1,
"DNA methylation":1,
"chromosomal instability":1,
"gene expression":1,
"Cadmium":1,
"Chromium":1,
"Cobalt":1,
"Copper":1,
"Lead":1,
"Thyroid diseases":1,
"Zinc":1,
"Clinicopathological characteristics":2,
"Small cell lung cancer":1,
"Systemic review and meta-analysis":1,
"Thyroid transcription factor-1":1,
"Communication":1,
"Coping":1,
"Distress":1,
"Histopathology":2,
"Influence":1,
"deceased donor":1,
"frozen section":1,
"transplantation":1,
"BLU-667":1,
"Fusion":1,
"LOXO-292":1,
"NSCLC":1,
"Pralsetinib":1,
"Rearrangement":1,
"Selpercatinib":1,
"Solid":1,
"Naringin":1,
"PI3K/AKT pathway":1,
"breast tumor":1,
"double-load and -response":1,
"drug delivery":1,
"mesoporous silica nanoparticles (MSNs)":1,
"proapoptotic peptide":1,
"systematic review":2,
"Carpesium abrotanoides L":1,
"glycolysis":2,
"medicinal&nbsp":1,
"plant":1,
"Bilateral diffuse uveal melanocytic proliferation":1,
"infrared imaging":1,
"Adverse vascular remodeling":1,
"Angiopoietin2":1,
"Cardiovascular disease":1,
"Low T3 state":1,
"galectin-3":1,
"targeted therapy":2,
"thyroid cancer diagnostic imaging":1,
"LINC00152":1,
"SNHG12":1,
"clinicopathologic characteristics":1,
"long noncoding RNAs":1,
"progression":2,
"distant metastasis":1,
"Central compartment dissection":1,
"ethanol":1,
"nerve injury":1,
"hyperfunctioning thyroid carcinoma":1,
"hyperthyroidism":1,
"malignant hot thyroid nodule":1,
"MET":1,
"circ5912":1,
"CADs":1,
"Experienced radiologists":1,
"Balance factor":1,
"Generalized clustering":1,
"Object segmentation":1,
"Spatial structure":1,
"DNA methylation profile":1,
"gene expression profile":1,
"pathogenic biomarkers":1,
"Ovarian cancer":1,
"PTEN":1,
"miR-552":1,
"Tetrac":1,
"angiogenesis":1,
"integrin αvβ3":1,
"mesenchymal stem cells":1,
"thyroid hormones":1,
"Del-1":1,
"developmental endothelial locus-1":1,
"miR-137":1,
"triple-negative breast cancer":1,
"MALAT1":1,
"METTL3":1,
"YAP":1,
"YTHDF1/3":1,
"eIF3b":1,
"m6A Modification":1,
"miR-1914-3p":1,
"March1":1,
"ciRs-6":1,
"Apatinib":1,
"vascular endothelial growth factor receptor":1,
"Juxtaposed with another zinc finger gene 1":1,
"NF-κB":1,
"TAK1":1,
"Follicular thyroid cancer":1,
"Interleukin-22":1,
"Sox17":1,
"TRIM30":1,
"Tripartite-motif protein 30":1,
"PI3K/Akt/mTOR signaling pathway":1,
"osteoglycin":1,
"small leucine-rich proteoglycans":1,
"anesthesia":1,
"conduction":1,
"conscious sedation":1,
"deep sedation":1,
"neoplasms":2,
"radiofrequency ablation":4,
"radiography":1,
"﻿interventional":1,
"Central compartment lymph node dissection":1,
"Hypocalcemia":1,
"Intact PTH (iPTH)":1,
"Morbidity":1,
"2019":1,
"Calcium (serum)":1,
"Calcium (urine)":1,
"December":1,
"Fatigue":1,
"Female":1,
"Hypercalcaemia":1,
"Hyperparathyroidism (primary)":1,
"Lymph node dissection":1,
"PTH":1,
"Parathyroidectomy":1,
"Polydipsia":1,
"Polyuria":1,
"Pregnant adult":1,
"Radioiodine":1,
"Saline":1,
"Thyroid ultrasonography":1,
"Unique/unexpected symptoms or presentations of a disease":1,
"United Kingdom":1,
"White":1,
"Clinical effectiveness":1,
"accident at ChNPP":1,
"functional parameters":1,
"malignant tumors":1,
"mammary gland":1,
"structural parameters":1,
"Hepatocellular carcinoma":1,
"Liver":1,
"Resection":1,
"BCL2":1,
"Deregulated miRNAs":1,
"Differentially expressed genes (DEGs)":1,
"hsa-miR-181a-5p":1,
"Breast tumours":1,
"breast reconstruction":1,
"oncoplastic breast-conserving surgery":1,
"patient reported outcome measures":1,
"study protocol":1,
"real-time quantitative polymerase chain reaction":1,
"stanniocalcin 2":1,
"metabolic disturbances":1,
"nutritional status":1,
"solid tumors":1,
"thyroid disorders":1,
"PI3K/AKT/mTOR pathway":1,
"TDRG1":1,
"endometrial carcinoma":1,
"gastric cancer":1,
"growth":1,
"lncRNA Linc-pint":1,
"lncRNA PTCSC3":1,
"Papillary thyroid microcarcinoma":1,
"Ultrasonography":2,
"frequency":1,
"mortality":1,
"statistics":1,
"Carcinoma larynx":1,
"Total laryngectomy":1,
"Near-total laryngectomy":1,
"Pyriform fossa":1,
"Discharging ulcer":1,
"Fatal":1,
"Squamous metaplasia":1,
"dose modification":1,
"sarcopenia":1,
"toxicity":1,
"DIAPH1":1,
"GOLGA2":1,
"formin-like 1 (FMNL1)":1,
"mesenchymal subtype":1,
"clinical trials":1,
"multikinase inhibitors":1,
"pazopanib":1,
"sunitinib":1,
"GBS":1,
"Guillain-Barré Syndrome":1,
"paraneoplastic":1,
"BRAFV600E":1,
"progesterone receptor":1,
"Behavior":1,
"French Polynesia":1,
"Radiation":1,
"atmospheric nuclear weapons test":1,
"food consumption":1,
"LINC00460":1,
"Raf1":1,
"miR-485-5p":1,
"Carcinoma espinocelular":1,
"Glândula tireoide":1,
"Laringe":1,
"Laringectomia":1,
"Laryngectomy":1,
"Larynx":1,
"Squamous cell carcinoma":2,
"Tireoidectomia":1,
"TERT promoter mutations":1,
"ACDF":1,
"Anterior cervical Discectomy and Fusion":1,
"C7/T1 anterior discectomy":1,
"Cervicothoracic junction":1,
"Bladder metastasis":1,
"Nephrectomy":1,
"Renal cell carcinoma":1,
"Renal metastases":1,
"Sclerosing mucoepidermoid carcinoma with eosinophilia":1,
"V600E":1,
"Complication":1,
"Safety":1,
"Lateral circumflex femoral artery, descending branch":1,
"Microsurgery":1,
"Reconstructive surgical procedures":1,
"Surgical flaps":1,
"Tongue neoplasms":1,
"Children":1,
"Guidelines":1,
"Ganglioneuroma":1,
"Multiple endocrine neoplasm (MEN)":1,
"Papillary thyroid carcinoma (PCT)":1,
"Paratesticular tumour":1,
"GLUT":1,
"Glucose metabolism":1,
"Tumor differentiation":1,
"multiple endocrine neoplasia type 2":1,
"MIRN34 microRNA":1,
"Receptor, Notch1":1,
"Triple negative breast neoplasms":1,
"Blood proteins":1,
"PAK4 inhibitor":1,
"selective inhibitors of nuclear export":1,
"selinexor":1,
"therapy resistance":1,
"diabetes":1,
"population study":1,
"risk":1,
"matrix metalloproteinase-2":1,
"matrix metalloproteinase-9":1,
"tissue inhibitor of matrix metalloproteinase-1":1,
"EYA1":1,
"SIX1":1,
"STAT3 signal":1,
"thyroid papillary carcinoma":1,
"tumor growth":1,
"ATA risk stratification systems":1,
"Indian population":1,
"Kerala":1,
"Outcome":1,
"Validation":1,
"Intramuscular levothyroxine":1,
"Levothyroxine therapy":1,
"Refractory hypothyroidism":1,
"Chronic diseases":1,
"Reliability":1,
"Self-reported":1,
"Test-retest":1,
"ca-125":1,
"dystrophic calcification":1,
"orphan annie eye nuclei":1,
"ovarian tumor":1,
"psammoma body":1,
"stained glass appearance":1,
"surgical debulking":1,
"3D ultrasound":1,
"hyperparathyroidism":1,
"parathyroid adenoma":1,
"Papillary thyroid carcinoma (PTC)":1,
"dual-energy computed tomography (DECT)":1,
"ultrasonography (US)":1,
"BRAF mutation":1,
"contrast-enhanced ultrasonography":1,
"risk and prognosis":1,
"wide areas of China":1,
"FNAC":1,
"thyroglobulin antibodies":1,
"thyroid malignancy":1,
"Classical dendritic cells":1,
"Cross presentation":1,
"MHC I and II antigen presentation":1,
"Plasmacytoid dendritic cells":1,
"Review":1,
"Th polarization":1,
"C cell":1,
"FOXA1":1,
"Latin America":1,
"Uruguay":1,
"carcinoma, transitional cell":1,
"noncommunicable diseases":1,
"stomach neoplasms":1,
"testicular germ cell tumor":1,
"testicular neoplasms":1,
"tobacco":1,
"trends":1,
"urinary bladder neoplasms":1,
"uterine cervical neoplasms":1,
"Cholesterol, HDL":1,
"IGF1 protein, human":1,
"IGF2 protein, human":1,
"Insulin":1,
"Insulin-Like Growth Factor I":1,
"Insulin-Like Growth Factor II":1,
"Obesity, Abdominal":1,
"case-control studies":1,
"insulin resistance":1,
"metabolic syndrome":1,
"shear wave elastography":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年12月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
